KymaThera
Advancing the Next Wave of Precision Therapeutics
Watertown, United States · Founded 2024 · $148.0M raised
- Headquarters
- Watertown, Massachusetts
- Employees
- 51–200
- Founded
- 2024
- Business Model
- B2B
- Website
- kymathera.com
- Total Funding
- $148.0M
- Last Round
- $80.0M Series CDec 2022
- Rounds
- 3
About
KymaThera is a San Diego-based clinical-stage biopharma applying structure-based drug design to develop best-in-class small molecule therapeutics for oncology and fibrotic diseases. Selective PI3Kα inhibitors, ALK5 inhibitor, JAK2 inhibitors.
Summary
KymaThera is a Biotech company based in Watertown, United States, founded in 2024. It has raised $148.0M in total across 3 rounds, most recently a $80.0M Series C round in Dec 2022. Investors include Venrock, Sands Capital and Cormorant Asset Management.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2022
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...